\contentsline {chapter}{Preamble about Interdisciplinary Research}{15}{chapter*.6}
\contentsline {section}{What does interdisciplinarity in science mean in XXI century?}{16}{section*.7}
\contentsline {section}{Strengths, Weaknesses Opportunities, Threats (SWOT) of an interdisciplinary PhD - personal perspective}{20}{section*.10}
\contentsline {section}{General context of the thesis}{20}{section*.12}
\contentsline {section}{Organisation of the dissertation}{22}{section*.13}
\contentsline {chapter}{\numberline {1}Immuno-biology of cancer}{25}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer disease}{25}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Historical understanding of cancer}{26}{subsection.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}Tumor micro environment as a complex system}{28}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}What is Tumor Microenvironment (TME)}{29}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Interactions between TME and Tumor}{30}{subsubsection.1.1.2.2}
\contentsline {paragraph}{\numberline {1.1.2.2.1}TME as a foe: inflammation}{30}{paragraph.1.1.2.2.1}
\contentsline {paragraph}{\numberline {1.1.2.2.2}TME seen as neutral}{32}{paragraph.1.1.2.2.2}
\contentsline {paragraph}{\numberline {1.1.2.2.3}TME as a friend: immunosurveillance}{32}{paragraph.1.1.2.2.3}
\contentsline {subsubsection}{\numberline {1.1.2.3}Two-faced nature of immune cells: context-dependent functional plasticity}{33}{subsubsection.1.1.2.3}
\contentsline {subsubsection}{\numberline {1.1.2.4}Immune cell (sub)types in TME}{34}{subsubsection.1.1.2.4}
\contentsline {subsubsection}{\numberline {1.1.2.5}Summary}{34}{subsubsection.1.1.2.5}
\contentsline {section}{\numberline {1.2}Quantifying and qualifying immune infiltration (data)}{35}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Cell sorting}{35}{subsection.1.2.1}
\contentsline {subsubsection}{\numberline {1.2.1.1}Flow cytometry}{35}{subsubsection.1.2.1.1}
\contentsline {subsubsection}{\numberline {1.2.1.2}Mass cytometry}{36}{subsubsection.1.2.1.2}
\contentsline {subsection}{\numberline {1.2.2}Microscope Staining}{36}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}omics}{36}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Transcriptome}{37}{subsubsection.1.2.3.1}
\contentsline {subsubsection}{\numberline {1.2.3.2}Epigenome}{37}{subsubsection.1.2.3.2}
\contentsline {subsubsection}{\numberline {1.2.3.3}Single cell RNA-seq}{39}{subsubsection.1.2.3.3}
\contentsline {section}{\numberline {1.3}From cancer phenotyping to immune therapies}{40}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}Cancer immune phenotypes}{40}{subsection.1.3.1}
\contentsline {subsubsection}{\numberline {1.3.1.1}Immunoscore}{41}{subsubsection.1.3.1.1}
\contentsline {subsubsection}{\numberline {1.3.1.2}Immunophenoscore}{43}{subsubsection.1.3.1.2}
\contentsline {subsubsection}{\numberline {1.3.1.3}Immune maps}{44}{subsubsection.1.3.1.3}
\contentsline {subsubsection}{\numberline {1.3.1.4}Summary}{44}{subsubsection.1.3.1.4}
\contentsline {subsection}{\numberline {1.3.2}Immune signatures - biological perspective}{44}{subsection.1.3.2}
\contentsline {subsection}{\numberline {1.3.3}Cancer therapies}{44}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Recent progress in immuno-therapies}{45}{subsection.1.3.4}
\contentsline {section}{\numberline {1.4}Biological dimension of the thesis}{46}{section.1.4}
\contentsline {chapter}{\numberline {2}Mathematical foundation of cell-type deconvolution of biological data}{49}{chapter.2}
\contentsline {section}{\numberline {2.1}Introduction to supervised and unsupervised learning}{49}{section.2.1}
\contentsline {section}{\numberline {2.2}Blind source separation}{49}{section.2.2}
\contentsline {section}{\numberline {2.3}Finding optimal number of components and over-decomposition of transcriptopmes}{51}{section.2.3}
\contentsline {section}{\numberline {2.4}Cell-type deconvolution models}{65}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}basis matrix}{65}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}regression algorithm}{65}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Others}{65}{subsection.2.4.3}
\contentsline {section}{\numberline {2.5}Short review of most popular cell-type deconvolution tools}{65}{section.2.5}
\contentsline {section}{\numberline {2.6}Methodological dimension of the thesis}{65}{section.2.6}
\contentsline {chapter}{\numberline {3}Study of sensitivity and reproducibility of known methods}{67}{chapter.3}
\contentsline {section}{\numberline {3.1}Reproducibility of NMF versus ICA (vs CAM?)}{67}{section.3.1}
\contentsline {subsection}{\numberline {3.1.1}Comparing metagenes obtained with NMF vs ICA.}{67}{subsection.3.1.1}
\contentsline {section}{\numberline {3.2}Impact of modification of signatures list on result for signature-based deconvolution methods}{70}{section.3.2}
\contentsline {chapter}{\numberline {4}Deconvolution of transcriptomes and methylomes}{71}{chapter.4}
\contentsline {section}{\numberline {4.1}From blind deconvolution to cell-type quantification: general overview}{71}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}The ICA-based deconvolution of Transcriptomes}{71}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Interpretation of Independent components}{72}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Correlation based identification of confounding factors}{72}{subsubsection.4.1.2.1}
\contentsline {subsubsection}{\numberline {4.1.2.2}Identification of immune cell types with enrichment test / other}{72}{subsubsection.4.1.2.2}
\contentsline {subsection}{\numberline {4.1.3}Transforming metagenes into signature matrix}{72}{subsection.4.1.3}
\contentsline {subsection}{\numberline {4.1.4}Regression-based estimation of cell-type proportions : solving system of equations}{72}{subsection.4.1.4}
\contentsline {section}{\numberline {4.2}\emph {DeconICA} R package for ICA-based deconvolution}{72}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}\emph {Demo}}{72}{subsection.4.2.1}
\contentsline {chapter}{\numberline {5}Comparative analysis of cancer immune infiltration}{89}{chapter.5}
\contentsline {chapter}{\numberline {6}Heterogeneity of immune cell types}{91}{chapter.6}
\contentsline {chapter}{\numberline {7}Conclusions and perspectives}{97}{chapter.7}
\contentsline {chapter}{Annexes}{99}{chapter*.24}
\contentsline {section}{PhD timeline for defence before the end of October 2018}{99}{section*.25}
\contentsline {section}{Thesis writing}{99}{section*.27}
\contentsline {section}{Activity Report 2017}{101}{section*.28}
